Activation of the A3 Adenosine Receptor Suppresses Superoxide Production and Chemotaxis of Mouse Bone Marrow Neutrophils
- 1 September 2008
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 74 (3) , 685-696
Abstract
Adenosine is formed in injured/ischemic tissues, where it suppresses the actions of essentially all cells of the immune system. Most of the anti-inflammatory actions of adenosine have been attributed to signaling through the Gs protein-coupled A2A adenosine receptor (AR). Here, we report that the A3AR is highly expressed in murine neutrophils isolated from bone marrow. Selective activation of the A3AR with (2S,3S,4R,5R)-3-amino-5-[6-(2,5-dichlorobenzylamino)purin-9-yl]-4-hydroxytetrahydrofuran-2-carboxylic acid methylamide (CP-532,903) potently inhibited mouse bone marrow neutrophil superoxide generation and chemotaxis induced by various activating agents. The selectivity of CP-532,903 was confirmed in assays using neutrophils obtained from A2AAR and A3AR gene “knockout” mice. In a model of thioglycollate-induced inflammation, treating mice with CP-532,903 inhibited recruitment of leukocytes into the peritoneum by specifically activating the A3AR. Collectively, our findings support the theory that the A3AR contributes to the anti-inflammatory actions of adenosine on neutrophils and provide a potential mechanistic explanation for the efficacy of A3AR agonists in animal models of inflammation (i.e., inhibition of neutrophil-mediated tissue injury).Keywords
This publication has 42 references indexed in Scilit:
- The A3 Adenosine Receptor Agonist CP-532,903 [N6-(2,5-Dichlorobenzyl)-3′-aminoadenosine-5′-N-methylcarboxamide] Protects against Myocardial Ischemia/Reperfusion Injury via the Sarcolemmal ATP-Sensitive Potassium ChannelThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Adenosine A2a receptors induce heterologous desensitization of chemokine receptorsBlood, 2006
- Neutrophils and immunity: challenges and opportunitiesNature Reviews Immunology, 2006
- Immunomodulatory impact of the A 2A adenosine receptor on the profile of chemokines produced by neutrophilsThe FASEB Journal, 2005
- Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-κB in A2A adenosine receptor inductionBiochemical Journal, 2005
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004
- Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: Evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritisArthritis & Rheumatism, 2000
- Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functionsTrends in Pharmacological Sciences, 1994
- Adenosine promotes neutrophil chemotaxis.Journal of Experimental Medicine, 1988